Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
H-CLAVYQAGAR^-OH
3D-Ansicht

Biosynth logo

H-CLAVYQAGAR^-OH

Ref. 3D-PP47637

Unbestimmte GrößeNachfragen
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 13. Dezember 2024

Produktinformation

Name:
H-CLAVYQAGAR^-OH
Beschreibung:

Peptide H-CLAVYQAGAR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CLAVYQAGAR^-OH include the following: Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study V Blanchard , S Ramin-Mangata - Journal of Lipid , 2018 - ASBMBhttps://www.jlr.org/article/S0022-2275(20)33124-2/fulltext The role of apolipoprotein E in neurodegeneration and cardiovascular disease MF Lopez, B Krastins, MM Ning - Expert review of proteomics, 2014 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1586/14789450.2014.901892 Quantitation of 87 proteins by nLC-MRM/MS in human plasma: workflow for large-scale analysis of biobank samples M Rezeli , K Sjödin, H Lindberg - Journal of proteome , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jproteome.7b00235 Quantification of total apolipoprotein E and its specific isoforms in cerebrospinal fluid and blood in Alzheimer's disease and other neurodegenerative diseases M Rezeli , H Zetterberg , K Blennow, A Brinkmalm - EuPA Open , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2212968515300143 EuPA Open Proteomics M Rezeli , H Zetterberg , K Blennow, A Brinkmalm - cyberleninka.orghttps://cyberleninka.org/article/n/135520.pdf Human apolipoprotein e resequencing by proteomic analysis and its application to serotyping M Nishimura, M Satoh , S Nishimura, S Kakinuma - Plos one, 2014 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085356 Human Apolipoprotein E Resequencing by Proteomic Analysis and Its Application M Nishimura , M Satoh , S Nishimura, S Kakinuma - 2014 - academia.eduhttps://www.academia.edu/download/53350102/Human_Apolipoprotein_E_Resequencing_by_P20170531-28951-1anyn57.pdf Mass spectrometry-based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids M Korecka, LM Shaw - Journal of neurochemistry, 2021 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/jnc.15465 In vivo human apolipoprotein E isoform fractional turnover rates in the CNS KR Wildsmith, JM Basak , BW Patterson, Y Pyatkivskyy - PloS one, 2012 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0038013 Method for the simultaneous quantitation of apolipoprotein E isoforms using tandem mass spectrometry KR Wildsmith, B Han, RJ Bateman - Analytical biochemistry, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003269709005363 Automated multiplex LC-MS/MS assay for quantifying serum apolipoproteins AI, B, CI, C-II, C-III, and E with qualitative apolipoprotein e phenotyping I van den Broek, FP Romijn, J Nouta - Clinical , 2016 - academic.oup.comhttps://academic.oup.com/clinchem/article-abstract/62/1/188/5611795 Simultaneous mass spectrometry-based apolipoprotein profiling and apolipoprotein E phenotyping in patients with ASCVD and mild cognitive impairment I Begcevic Brkovic, B Zöhrer, M Scholz, M Reinicke - Nutrients, 2022 - mdpi.comhttps://www.mdpi.com/2072-6643/14/12/2474 Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls E Martaca­nez-Morillo , O Hansson , Y Atagi, G Bu - Acta , 2014 - Springerhttps://link.springer.com/article/10.1007/s00401-014-1266-2 Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e E Martaca­nez-Morillo , HM Nielsen, I Batruch - Journal of proteome , 2014 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr401060x New plasma LC-MS/MS assays for the quantitation of beta-amyloid peptides and identification of apolipoprotein E proteoforms for Alzheimer's disease risk DM Weber , JC Kim, SM Goldman - Journal of , 2023 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/10815589241246537 MSACL 2023 Abstract (s) for Proteomics D Qasrawi - msacl.orghttps://www.msacl.org/program/view_abstract_selection.php?topic=Proteomics&event=2023 Towards an SI-traceable reference measurement system for seven serum apolipoproteins using bottom-up quantitative proteomics: conceptual approach enabled by CM Cobbaert, H Althaus, I Begcevic Brkovic - Clinical , 2021 - academic.oup.comhttps://academic.oup.com/clinchem/article-abstract/67/3/478/6040690 Applying log-normal peak fitting to parallel reaction monitoring data analysis C Stingl, TM Luider - Journal of Proteome Research, 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jproteome.1c00371 Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing C Hirtz , J Vialaret , G Nouadje, S Schraen, P Benlian - Clinica Chimica , 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0009898115300917 Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease A Giannisis, A Al-Grety, H Carlsson, K Patra - Alzheimer's research & , 2022 - Springerhttps://link.springer.com/article/10.1186/s13195-022-01058-9 Plasma apolipoprotein E levels, isoform composition, and dimer profile in relation to plasma lipids in racially diverse patients with Alzheimer's disease and mild A Giannisis, A Al-Grety, H Carlsson, JC Howell - Alzheimer's Research & , 2023 - Springerhttps://link.springer.com/article/10.1186/s13195-023-01262-1

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP47637 H-CLAVYQAGAR^-OH

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.